Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Operating Leases (2019 - 2025)

Select Medical Holdings (SEM) has disclosed Operating Leases for 7 consecutive years, with $818.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 29.64% to $818.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $818.6 million, a 29.64% decrease, with the full-year FY2024 number at $787.1 million, down 23.27% from a year prior.
  • Operating Leases was $818.6 million for Q3 2025 at Select Medical Holdings, roughly flat from $818.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.2 billion in Q3 2024 to a low of $787.1 million in Q4 2024.
  • A 5-year average of $961.4 million and a median of $1.0 billion in 2024 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: grew 14.15% in 2024, then dropped 29.64% in 2025.
  • Select Medical Holdings' Operating Leases stood at $916.5 million in 2021, then rose by 10.02% to $1.0 billion in 2022, then rose by 1.73% to $1.0 billion in 2023, then fell by 23.27% to $787.1 million in 2024, then rose by 4.0% to $818.6 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Operating Leases are $818.6 million (Q3 2025), $818.1 million (Q2 2025), and $787.9 million (Q1 2025).